CLINICAL_TRIALS
trial_result
· 2015-01-06
Clinical Trial Update: Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer [Phase 1, Phase 2]
Summary
Phase 1/2 trial of amrubicin in HER2-negative metastatic breast cancer completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SCRI Development Innovations, LLC | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-01-06